Ulta Beauty, Inc. (ULTA) J.P. Morgan's 11th Annual Retail Round Up Conference (Transcript)
https://seekingalpha.com/article/4772848-ulta-beauty-inc-ulta-j-p-morgans-11th-annual-retail-round-up-conference-transcript?source=feed_sector_transcripts
Apr 03, 2025 -
0
AngioDynamics Q3 Results Beat Expectations; Raises Annual Outlook Above View; Stock Up In Pre-market
https://www.rttnews.com/story.aspx?Id=3526211
Apr 02, 2025 - AngioDynamics, Inc. (ANGO) Wednesday reported net loss of $4.41 million or $0.11 per share for the third quarter, significantly lower than $187.74 million or $4.67 per share loss in the same quarter a year ago, primarily due to goodwill impairment charges of $159.48 million in the prior-year quarter. The medical technology company's shares were more than 10 percent up in pre-market.
0
Sweetgreen: Tough Set Up For The Rest Of 2025 (Rating Downgrade)
https://seekingalpha.com/article/4773196-sweetgreen-tough-set-up-for-the-rest-of-2025-rating-downgrade?source=feed_all_articles
Apr 05, 2025 -
0
Pamt Corp. Stock UP In Pre-market; Commences Self Tender Offer To Repurchase Up To 435,000 Shares
https://www.rttnews.com/story.aspx?Id=3526852
Apr 04, 2025 - Shares of Pamt Corp. (PAMT), a truckload transportation and logistics company, were rising more than 25 percent in pre-market on Friday.
0
KalVista Pharma Licenses Sebetralstat For HAE To Kaken Pharma In Japan For Up To $22 Mln; Stocks Up
https://www.rttnews.com/story.aspx?Id=3527440
Apr 08, 2025 - Shares of KalVista Pharmaceuticals, Inc. (KALV) were gaining around 5 percent in the pre-market activity on the Nasdaq, after the company announced Tuesday that its unit, KalVista Pharmaceuticals, Ltd., has licensed commercialization rights in Japan to Kaken Pharmaceutical, Co., Ltd. (KKPCF) for sebetralstat.
0
Walgreens Q2 Loss Narrows; Adj. Earnings, Sales Beat Market; Stock Up
https://www.rttnews.com/story.aspx?Id=3527411
Apr 08, 2025 - Shares of Walgreens Boots Alliance, which is in deal to be taken private by Sycamore Partners, were gaining around 3 percent in the pre-market activity on the Nasdaq, after the company reported Tuesday sharply narrower net loss in its second quarter with higher net sales. Adjusted earnings and top line beat market estimates.
0
Earn Up To 12% Yield While Living The American Dream
https://seekingalpha.com/article/4774171-up-to-12-percent-yield-living-american-dream?source=feed
Apr 11, 2025 -
0
SCHD's Portfolio Shake-Up: What It Means For Investors (Rating Downgrade)
https://seekingalpha.com/article/4774614-schds-portfolio-shake-up-what-it-means-for-investors-downgrade?source=feed
Apr 13, 2025 -
0
Third Harmonic Bio To Liquidate, To Distribute Up To $255.4 Mln To Shareholders; Stock Climbs
https://www.rttnews.com/story.aspx?Id=3528499
Apr 14, 2025 - Shares of Third Harmonic Bio, Inc. (THRD) were surging around 38 percent in the pre-market activity on the Nasdaq, after the clinical-stage biopharmaceutical company announced Monday that its board of directors has approved a plan to liquidate and dissolute the firm and to distribute remaining cash to stockholders following an orderly wind down of the company's operations.
0
USANA's Resurfacing Serum Shows Improvements In Skin Appearance In Two Weeks, Stock Up In Pre-Market
https://www.rttnews.com/story.aspx?Id=3528530
Apr 14, 2025 - USANA Health Sciences, Inc. (USNA), Monday announced the results of a clinical study on its Celavive Resurfacing Serum, showing statistically significant improvements in the appearance of their skin in just two weeks.
0
Page 1>